JPH0443070B2 - - Google Patents
Info
- Publication number
- JPH0443070B2 JPH0443070B2 JP56154887A JP15488781A JPH0443070B2 JP H0443070 B2 JPH0443070 B2 JP H0443070B2 JP 56154887 A JP56154887 A JP 56154887A JP 15488781 A JP15488781 A JP 15488781A JP H0443070 B2 JPH0443070 B2 JP H0443070B2
- Authority
- JP
- Japan
- Prior art keywords
- crystalline form
- ranitidine hydrochloride
- ranitidine
- hydrochloride
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8031634 | 1980-10-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5791983A JPS5791983A (en) | 1982-06-08 |
| JPH0443070B2 true JPH0443070B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-07-15 |
Family
ID=10516407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56154887A Granted JPS5791983A (en) | 1980-10-01 | 1981-10-01 | Ranitidine, manufacture and medicinal composition containing same |
Country Status (29)
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR242029A1 (es) * | 1983-07-15 | 1993-02-26 | Richter Gedeon Vegyeszet | Procedimiento para la preparacion del clorhidrato de 1-(2-(5- dimetilaminometil-2-(furilmetiltio)-etil))-amino-1-metilamino-2-nitroetileno |
| GB8629781D0 (en) * | 1986-12-12 | 1987-01-21 | Glaxo Group Ltd | Pharmaceutical compositions |
| SE8704436D0 (sv) * | 1987-11-13 | 1987-11-13 | Pm Konsult Handelsbolag | Anvendning av antisekretoriska substanser for nya indikationer |
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it |
| GB8904182D0 (en) * | 1989-02-23 | 1989-04-05 | Glaxo Canada | Pharmaceutical compositions |
| US5169864A (en) * | 1991-11-15 | 1992-12-08 | Baxter International Inc. | Unbuffered premixed ranitidine formulation |
| CN1048984C (zh) * | 1991-12-20 | 2000-02-02 | 多坎化学有限公司 | 晶形1呋喃硝胺氢氯化物的制备 |
| US5338871A (en) * | 1991-12-20 | 1994-08-16 | Torcan Chemical Ltd. | Preparation of form 1 ranitidine hydrochloride |
| ES2157254T3 (es) * | 1993-03-12 | 2001-08-16 | Upjohn Co | Ceftiofur (acido libre) cristalino. |
| DE4341310A1 (de) * | 1993-12-03 | 1995-06-08 | Hexal Pharma Gmbh | Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1 |
| US5407687A (en) * | 1994-02-22 | 1995-04-18 | Glaxo Inc. | Ranitidine solid dosage form |
| US5670671A (en) * | 1994-04-08 | 1997-09-23 | Brantford Chemicals Inc. | Process for the production of an improved form of form 1 ranitidine |
| CA2120874E (en) * | 1994-04-08 | 2002-01-08 | Keshava Murthy | Form of form 1 ranitidine |
| ES2164147T3 (es) | 1994-04-15 | 2002-02-16 | Upjohn Co | Nuevas formas cristalinas de la 2-(5-metanosulfonamido-indolil-2-carbonil)-4-(3-(1-metiletilamino)-2-piperidinil)piperazina. |
| NZ272054A (en) * | 1994-05-13 | 1996-05-28 | Ranbaxy Lab Ltd | Process for producing form 1 ranitidine hydrochloride |
| IN181699B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1994-05-13 | 1998-09-05 | Ranbaxy Lab Ltd | |
| IN181698B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1994-05-13 | 1998-09-05 | Ranbaxy Lab Ltd | |
| FI964565A0 (fi) * | 1994-05-18 | 1996-11-14 | Hoechst Marion Roussel Inc | Menetelmiä antihistamiinisten piperidiinijohdosten vedettömien ja hydratoituneiden muotojen, niiden polymorfien ja pseudomorfien, valmistamiseksi |
| US20030045722A1 (en) * | 1994-05-18 | 2003-03-06 | Henton Daniel R. | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| EP0694540B1 (en) | 1994-06-24 | 1998-08-19 | Ranbaxy Laboratories Limited | Process for the manufacture of form 1 ranitidine hydrochloride |
| FI972103L (fi) * | 1994-11-18 | 1997-05-16 | Upjohn Co | Fluorokinolonin uusi fysikaalisesti stabiili kiinteä muoto |
| US5538737A (en) * | 1994-11-30 | 1996-07-23 | Applied Analytical Industries, Inc. | Oral compositions of H2 -antagonists |
| US5663381A (en) * | 1995-04-21 | 1997-09-02 | Hexal Pharmaceuticals, Inc. | Process for preparing form 1 ranitidine hydrochloride |
| US5686588A (en) * | 1995-08-16 | 1997-11-11 | Yoo; Seo Hong | Amine acid salt compounds and process for the production thereof |
| WO1997035853A1 (en) * | 1996-03-25 | 1997-10-02 | Hoechst Marion Roussel, Inc. | Process for the preparation of form 1 ranitidine hydrochloride |
| DE59801792D1 (de) * | 1997-08-08 | 2001-11-22 | Aventis Pharma Gmbh | Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid |
| US6287693B1 (en) | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
| IT1317858B1 (it) * | 2000-02-29 | 2003-07-15 | Pharmexcel S R L | Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione |
| GB2357762B (en) * | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
| US20020183553A1 (en) * | 2000-10-19 | 2002-12-05 | Ben-Zion Dolitzky | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
| US20060173064A1 (en) * | 2001-08-24 | 2006-08-03 | Lippa Arnold S | (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders |
| US6569887B2 (en) * | 2001-08-24 | 2003-05-27 | Dov Pharmaceuticals Inc. | (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake |
| US7235655B2 (en) * | 2002-03-22 | 2007-06-26 | Pharmacia & Upjohn Company | Processes to prepare eplerenone |
| AR040661A1 (es) * | 2002-07-26 | 2005-04-13 | Theravance Inc | Diclorhidrato cristalino de n-{2-[-((r)-2-hidroxi-2-feniletilamino)fenil]etil}-(r)-2hidroxi-2-(3-formamido-4-hidroxifenil)etilamina, agonista del receptor adrenergico beta 2 |
| US20080081834A1 (en) | 2002-07-31 | 2008-04-03 | Lippa Arnold S | Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders |
| US7166641B2 (en) * | 2002-10-02 | 2007-01-23 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
| JP2006519162A (ja) * | 2002-11-08 | 2006-08-24 | ディオーブイ ファーマシューティカル，インク． | ビシファジン塩酸塩の多形 |
| TW200510277A (en) * | 2003-05-27 | 2005-03-16 | Theravance Inc | Crystalline form of β2-adrenergic receptor agonist |
| US7384557B2 (en) * | 2003-07-14 | 2008-06-10 | Applied Ambient Extraction Process Consultants, Llc | Method and apparatus for removing solute from a solid solute-bearing product |
| TWI328006B (en) * | 2003-12-26 | 2010-08-01 | Nissan Chemical Ind Ltd | Crystal form of quinoline compound and process for its production |
| US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
| US20060100263A1 (en) * | 2004-11-05 | 2006-05-11 | Anthony Basile | Antipyretic compositions and methods |
| US20060100271A1 (en) * | 2004-11-08 | 2006-05-11 | Keith Whitehead | Stabilized aqueous ranitidine compositions |
| EP1915146A4 (en) | 2005-07-27 | 2010-06-02 | Dov Pharmaceutical Inc | NOVEL 1-ARYL-3-AZABICYCLO [3.1.0] HEXANEES. PREPARATION AND USE FOR THE TREATMENT OF NEUROPSYCHIATRIC DISEASES |
| DE102005035891A1 (de) * | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| US20080045725A1 (en) * | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
| EP2094084A4 (en) * | 2006-10-20 | 2010-01-13 | Scinopharm Singapore Pte Ltd | PROCESS FOR PREPARING CRYSTALLINE WATER-FREE DOCETAXEL |
| US8138377B2 (en) | 2006-11-07 | 2012-03-20 | Dov Pharmaceutical, Inc. | Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
| US20090069374A1 (en) * | 2007-06-06 | 2009-03-12 | Phil Skolnick | Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments |
| US9133159B2 (en) | 2007-06-06 | 2015-09-15 | Neurovance, Inc. | 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| TW201011043A (en) * | 2008-06-20 | 2010-03-16 | Chugai Pharmaceutical Co Ltd | Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives |
| CN103619823B (zh) | 2011-06-30 | 2016-01-20 | 东丽株式会社 | 甘氨酸衍生物的晶体及其药物用途 |
| US20140206740A1 (en) | 2011-07-30 | 2014-07-24 | Neurovance, Inc. | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
| CN106432148B (zh) * | 2015-05-26 | 2018-04-17 | 烟台市华文欣欣医药科技有限公司 | 一种治疗胃病的药物盐酸雷尼替丁化合物的制备方法 |
| CN105030694A (zh) * | 2015-08-04 | 2015-11-11 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂 |
| CN104971053A (zh) * | 2015-08-05 | 2015-10-14 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗消化系统疾病的药物盐酸雷尼替丁组合物片剂 |
| CN105055331A (zh) * | 2015-08-31 | 2015-11-18 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗消化性溃疡的药物盐酸雷尼替丁组合物颗粒剂 |
| WO2021079183A1 (en) * | 2019-10-21 | 2021-04-29 | Sms Pharmaceuticals Limited | Isopropyl alcohol solvent free crystalline ranitidine hydrochloride form-2 which is free of nitrosamine (ndma) impurity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
| US4233302A (en) * | 1977-12-23 | 1980-11-11 | Glaxo Group Limited | Amine derivatives and pharmaceutical compositions containing them |
-
1981
- 1981-09-28 IL IL63968A patent/IL63968A/xx unknown
- 1981-09-29 PT PT73744A patent/PT73744B/pt unknown
- 1981-10-01 ZA ZA816809A patent/ZA816809B/xx unknown
- 1981-10-01 DE DE19813139134 patent/DE3139134A1/de active Granted
- 1981-10-01 FR FR8118528A patent/FR2491067A1/fr active Granted
- 1981-10-01 CH CH6322/81A patent/CH652122A5/fr not_active IP Right Cessation
- 1981-10-01 IE IE2287/81A patent/IE51604B1/en not_active IP Right Cessation
- 1981-10-01 AU AU75955/81A patent/AU549119B2/en not_active Expired
- 1981-10-01 NL NL8104482A patent/NL8104482A/nl active Search and Examination
- 1981-10-01 KR KR1019810003689A patent/KR870001431B1/ko not_active Expired
- 1981-10-01 IT IT49407/81A patent/IT1143237B/it active
- 1981-10-01 PH PH26300A patent/PH19489A/en unknown
- 1981-10-01 ZW ZW244/81A patent/ZW24481A1/xx unknown
- 1981-10-01 DK DK436281A patent/DK167794B1/da not_active IP Right Cessation
- 1981-10-01 BE BE0/206126A patent/BE890574A/fr not_active IP Right Cessation
- 1981-10-01 JP JP56154887A patent/JPS5791983A/ja active Granted
- 1981-10-01 CA CA000387135A patent/CA1202638A/en not_active Expired
- 1981-10-01 AT AT0422281A patent/AT389696B/de not_active IP Right Cessation
- 1981-10-01 SE SE8105812A patent/SE453500B/sv not_active IP Right Cessation
- 1981-10-01 LU LU83661A patent/LU83661A1/fr unknown
- 1981-10-01 NZ NZ198522A patent/NZ198522A/en unknown
- 1981-10-01 GR GR66187A patent/GR72499B/el unknown
- 1981-10-01 ES ES505951A patent/ES8301954A1/es not_active Expired
-
1982
- 1982-08-09 US US06/406,710 patent/US4521431A/en not_active Expired - Lifetime
-
1985
- 1985-03-18 US US06/712,610 patent/US4672133A/en not_active Expired - Lifetime
- 1985-07-17 KE KE3549A patent/KE3549A/xx unknown
- 1985-12-05 HK HK979/85A patent/HK97985A/xx not_active IP Right Cessation
- 1985-12-20 PH PH33229A patent/PH21761A/en unknown
- 1985-12-30 MY MY747/85A patent/MY8500747A/xx unknown
-
1991
- 1991-12-23 SK SK4035-91A patent/SK403591A3/sk unknown
- 1991-12-23 CZ CS914035A patent/CZ280885B6/cs unknown
-
1992
- 1992-03-12 DK DK033792A patent/DK167923B1/da not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0443070B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| KR940008913B1 (ko) | N,n-디메틸-1-[1-(4-클로로페닐)-사이클로부틸]-3-메틸부틸아민 염산염 일수화물의 제조방법 | |
| JP2001508077A (ja) | ２−アミノ−４−（４−フルオルベンジルアミノ）−１−エトキシカルボニル−アミノベンゼンの新規変態ならびにその製造法 | |
| TW200944508A (en) | Novel solid forms of bendamustine hydrochloride | |
| CY1306A (en) | Aminoalkyl furan derivative | |
| HU196775B (en) | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances | |
| JP2001506279A (ja) | 結晶性マクロライドおよびその調製方法 | |
| CN110944979B (zh) | Odm-201晶型及其制备方法和药物组合物 | |
| EP3694843B1 (en) | New salt and solid state forms of escitalopram | |
| CN112094249B (zh) | 磺胺甲噻二唑-糖精共晶及其制备方法与应用 | |
| CN116199590B (zh) | 一种盐酸多巴酚丁胺及其注射剂 | |
| JP6496429B2 (ja) | アセチルサリチル酸誘導体の結晶及びその調製方法と用途 | |
| KR101285050B1 (ko) | 결정형 1Ｈ-이미다조[4,5-ｂ]피리딘-5-아민,7-[5-[(시클로헥실메틸아미노)-메틸]-1Ｈ-인돌-2-일]-2-메틸, 설페이트 (1:1), 삼수화물 및 이의 약학적 용도 | |
| AU691736B2 (en) | A process for preparing form 1 ranitidine hydrochloride | |
| JPH04502612A (ja) | 新規なｓ―チモロール誘導体及びその製造方法 | |
| CN103450099B (zh) | 阿那曲唑及其一水合物的新晶型、制备和用途 | |
| RU2203048C2 (ru) | Физически устойчивая рентгеноаморфная форма ранитидина гидрохлорида с повышенной противоязвенной активностью и способ ее получения | |
| JP2003511437A (ja) | Ｎ−［３−［［２−（３，４−ジメトキシフェニル）エチル］アミノ］プロピル］−４−ニトロベンズアミド塩酸塩の多型相 | |
| JPS5916820A (ja) | 無晶形マロチラ−トを含有する固形製剤組成物 | |
| HK1248213A1 (zh) | Abexinostat 甲苯磺酸盐及相关的晶体形式的制备方法 | |
| MXPA97008122A (en) | A process for preparing ranitidine hydrochloride form | |
| JPH05155820A (ja) | Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法 | |
| JP2003511438A (ja) | 水和ｎ−［３−［［２−（３，４−ジメトキシフェニル）エチル］アミノ］プロピル］−４−ニトロベンズアミド塩酸塩およびその医薬組成物中における使用 | |
| HK1220965A1 (zh) | 新abexinostat盐、相关的晶体形式、其制备方法以及含有其的药物组合物 | |
| HK1220965B (en) | Novel abexinostat salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RVTR | Cancellation due to determination of trial for invalidation |